John Kirby
Interim CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Verrica Pharmaceuticals Inc. (VRCA) | Interim Chief Financial Officer | $480,000 | $614,600 |
| 2024 | Verrica Pharmaceuticals Inc. (VRCA) | Interim Chief Financial Officer | $73,333 | $114,587 |
Earnings-call appearances
-
Verrica Pharmaceuticals Inc. Q2 FY2026 Earnings Call2026-08-06
Verrica Pharmaceuticals Inc. (VRCA)
-
Verrica Pharmaceuticals Inc. Q1 FY2026 Earnings Call2026-05-12
Verrica Pharmaceuticals Inc. (VRCA)
-
Verrica Pharmaceuticals Inc. Q3 FY2025 Earnings Call2025-11-14
Verrica Pharmaceuticals Inc. (VRCA)
-
Verrica Pharmaceuticals Inc. Q2 FY2025 Earnings Call2025-08-12
Verrica Pharmaceuticals Inc. (VRCA)
-
Verrica Pharmaceuticals Inc. Q4 FY2024 Earnings Call2025-03-11
Verrica Pharmaceuticals Inc. (VRCA)